342 results on '"Dobricic, Valerija"'
Search Results
2. Genetic risk scores and hallucinations in patients with Parkinson disease
3. TREX1 p.A129fs and p.Y305C variants in a large multi-ethnic cohort of CADASIL-like unrelated patients
4. A correlation map of genome-wide DNA methylation patterns between paired human brain and buccal samples
5. Differential microRNA expression analyses across two brain regions in Alzheimer’s disease
6. Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
7. Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
8. Genetic Risk Factors in Isolated Dystonia Escape Genome‐Wide Association Studies.
9. Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD study.
10. CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease.
11. Genome-wide meta-analysis of short-tandem repeats for Parkinson's disease risk using genotype imputation
12. Genome-wide QTL mapping across three tissues highlights several Alzheimer's and Parkinson's disease loci potentially acting via DNA methylation
13. Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer’s disease in the EMIF‐AD Multimodal Biomarker Discovery study
14. PHACTR1 genetic variability is not critical in small vessel ischemic disease patients and PcomA recruitment in C57BL/6J mice
15. Novel NAXE variants as a cause for neurometabolic disorder: implications for treatment
16. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
17. Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid
18. Inflammatory biomarkers in Alzheimer's disease plasma
19. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
20. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
21. Field synopsis and systematic meta-analyses of genetic association studies in isolated dystonia
22. Variants in the TERT gene increase the occurrence of solar lentigines by modifying telomerase expression exclusively in the skin
23. Blood-based multivariate methylation risk score for cognitive impairment and dementia
24. Variants in the TERT Gene Increase the Occurrence of Solar Lentigines by Modifying Telomerase Expression Exclusively in the Skin
25. A pilot study on predictors of brainstem raphe abnormality in patients with major depressive disorder
26. APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
27. Clinical spectrum of the pentanucleotide repeat expansion in the RFC1 gene in ataxia syndromes
28. Genetic risk for Alzheimer disease predicts hippocampal volume through the human lifespan
29. Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits
30. No increase of CD8+ TEMRA cells in the blood of healthy adults at high genetic risk of Alzheimer's disease.
31. CSF Proteome Changes Depend on APOE Genotype in Prodromal AD
32. Additional file 1 of Entorhinal cortex epigenome-wide association study highlights four novel loci showing differential methylation in Alzheimer’s disease
33. Whole‐exome rare‐variant analysis of Alzheimer's disease and related biomarker traits
34. Epigenome-Wide Association Study in Peripheral Tissues Highlights DNA Methylation Profiles Associated with Episodic Memory Performance in Humans
35. Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brains
36. Mutations in Niemann Pick type C gene are risk factor for Alzheimer’s disease
37. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study
38. TREX1 p.A129fs and p.Y305C variants in a large multi-ethnic cohort of CADASIL-like unrelated patients
39. Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non‐Alzheimer's disease pathophysiology
40. Transcranial sonography in patients with Parkinson's disease with glucocerebrosidase mutations
41. Novel GNB1 mutations disrupt assembly and function of G protein heterotrimers and cause global developmental delay in humans
42. Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non‐Alzheimer's disease pathophysiology.
43. Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2
44. Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
45. Additional file 2 of Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
46. Additional file 2 of A correlation map of genome-wide DNA methylation patterns between paired human brain and buccal samples
47. Clinical exome sequencing in Serbian patients with movement disorders: Single centre experience
48. Analysis of “clinical exome” panel in Serbian patients with cognitive disorders
49. C9ORF72 repeat expansion is not associated with atypical parkinsonism in the Serbian population
50. Genome-wide association study of Alzheimer's disease brain imaging biomarkers and neuropsychological phenotypes in the EMIF-AD Multimodal Biomarker Discovery dataset
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.